ArticleJournal of inflammation research2025
Macrophage-Derived Exosomal BMPR2 Mediates Alveolar Epithelial Repair and Cellular Crosstalk in Acute Lung Injury.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exosome Nanotherapy Rescues Male Fertility by Delivering Integrin β1 to Repair Environmental Stress-Damaged Testes.Molecular pharmaceutics · 2026Article
- STUB1-induced polyubiquitination of SIK3 in alveolar type 2 epithelial cells alleviates severity and outcomes of acute lung injury.Cell death & disease · 2026Article
- Innate immune circuits in acute lung injury: macrophage plasticity, ILC crosstalk, and tissue repair failure.Frontiers in immunology · 2026Review
- Cell-specific exosomes in sepsis-associated ARDS: from immunometabolic reprogramming to precision medicine.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute lung injury (ALI)/Acute respiratory distress syndrome (ARDS) continues to be a predominant cause of morbidity and mortality among critically ill patients, with few therapeutic options available. Although macrophage-derived exosomes have been identified as significant mediators of intercellular communication in tissue repair, their specific molecular mechanisms in the context of ALI remain inadequately understood. This study aims to investigate the role of macrophage-derived exosomes containing bone morphogenetic protein receptor 2 (BMPR2) in promoting the repair of blast-induced acute lung injury. Methods: We established an in vitro blast injury model utilizing MLE-12 alveolar epithelial cells and isolated exosomes from J774A.1 macrophages through ultracentrifugation. Coculture experiments were conducted to evaluate cellular repair mechanisms, while molecular docking simulations were employed to predict protein interactions. We utilized cellular thermal shift assay (CETSA) analysis, Western blotting, and immunofluorescence to characterize the effects of exosomes on epithelial cell function and signaling pathways. Results: Macrophage-derived exosomes, with a diameter of 169.7 ± 61.6 nm, significantly enhanced the viability of alveolar epithelial cells, reduced apoptosis, and promoted proliferation following blast injury. Proteomic analysis identified BMPR2 as the predominant effector protein, with an LG score of 5.182. Molecular docking studies revealed stable binding interactions between BMPR2 and BMPR1B. Functionally, exosomes facilitated the transdifferentiation of alveolar type II (AT2) cells to type I (AT1) cells through the activation of the TGF-β signaling pathway via the BMPR1B-SMAD1-ID1 axis, thereby promoting epithelial repair and regeneration. Conclusion: This study establishes that exosomal BMPR2 derived from macrophages serves as a previously unrecognized paracrine signaling mechanism facilitating cellular crosstalk during ALI repair. The BMPR2-mediated signaling pathway offers a promising therapeutic target for the treatment of ALI, paving the way for new avenues in clinical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.